RxEars Rxi vs Starkey Evolv AI

The RxEars Rxi is a budget-priced prescription hearing aid in an invisible-in-ear style, earning an A grade with a SoundScore of 4.1/5 in our lab testing. At $499, it represents one of the most affordable options in the prescription hearing aid category while still delivering solid overall performance. Speech clarity is a notable strength for this device. In quiet listening environments, the Rxi scores 4.3/5, which is 0.97 points above the category average—a strong result that should benefit users in conversational settings at home or in calm environments. Speech understanding in noisy conditions scores 2.1/5, slightly above the category average by 0.16 points, though this remains mixed in absolute terms and may present challenges in demanding acoustic situations like busy restaurants. Feedback handling is excellent at 4.7/5, essentially matching the category average and indicating reliable stability during daily wear. However, the Rxi shows notable limitations in other areas. Own-voice comfort scores 1.6/5, falling 1.15 points below the category average, which may result in a hollow or boomy perception of your own voice. Music streaming is not supported, scoring 0.0/5—a significant gap of 2.64 points below category average that buyers should consider if streaming audio matters to them. The RxEars Rxi is best suited for budget-conscious consumers who prioritize speech clarity in quieter environments and don't require streaming capabilities. Its invisible form factor and disposable battery design offer convenience, though those seeking better own-voice comfort or music features should explore alternatives.

The Starkey Evolv AI is a premium behind-the-ear prescription hearing aid released in 2022, currently available at $4,598. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #28 of 36 prescription hearing aids tested. This device shows notable strengths in specific performance areas. Music streaming quality stands out at 3.7/5, scoring 1.06 points above the category average—making it a solid choice for users who prioritize audio entertainment. Speech in noise performance reaches 2.8/5, which is 0.81 points above the category average, though the absolute score reflects mixed real-world performance in challenging listening environments. Speech in quiet is solid at 3.4/5, slightly above average. The Evolv AI does show weaknesses in two key areas. Own voice comfort scores 2.1/5, falling 0.65 points below the category average, which may affect how natural your own speech sounds. Feedback handling, while solid in absolute terms at 3.5/5, runs 1.21 points below the category average of 4.71/5—meaning competitors in this price tier generally offer better feedback suppression. At this premium price point, several alternatives deliver stronger overall performance, including the Phonak Sphere Infinio and Oticon Intent. However, the Evolv AI's Expert's Choice Award recognition in 2023 and 2024 reflects its practical strengths. This hearing aid may suit users who prioritize music streaming quality and improved speech understanding in noise over own-voice comfort, and who value Starkey's feature set including rechargeable batteries and hands-free calling for both iPhone and Android.